Comparison of the pharmacological mechanisms involved in the platelet lowering actions of anagrelide and hydroxyurea: a review.
Hong
Ying
Y
The Cell Biology Group, British Heart Foundation Laboratories, Department of Medicine, University College London, London, UK.
Erusalimsky
Jorge D
JD
D001792:Blood Platelets / Q000187:drug effects*; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000494:pharmacology*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000494:pharmacology; D011799:Quinazolines / Q000009:adverse effects / Q000494:pharmacology*; D018570:Risk Assessment; D013922:Thrombocytosis / Q000150:complications / Q000188:drug therapy
D010975:Platelet Aggregation Inhibitors; D011799:Quinazolines; C021139:anagrelide; D006918:Hydroxyurea